The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 129 participants.
Also called NCT04519489
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 129 participants
- Sponsor
- Registry
-
NCT04519489
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Terminated
Technical summary
Registry record NCT04519489. Randomized; no masking; primary purpose treatment. Start 2020-09-18 (actual); primary completion 2021-12-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA
- Acronym
- AFOSA
- Condition
- Atrial Fibrillation
- Condition
- Obstructive Sleep Apnea
- Intervention (Device)
- PAP therapy with telemonitoring
- Intervention (Other)
- AF standard management and OSA general care
- Lead sponsor
- Philips (China) Investment CO., LTD
- Collaborator
- Peking University First Hospital
- Collaborator
- Beijing Tsinghua Changgeng Hospital
- Collaborator
- Beijing Tongren Hospital
- Collaborator
- Fu Wai Hospital, Beijing, China
- Collaborator
- Shanghai 6th People's Hospital
- Collaborator
- Ruijin Hospital
Record details
- Record id
cardio:ct-nct04519489- Content hash
9ee16df8ef10129712002d67fe98d73ef101fc582e2c0cd650bb878bd7ebe3a7